OFLOXACIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ofloxacin, and what generic alternatives are available?
Ofloxacin is a drug marketed by Bedford, Altaire Pharms Inc, Alvogen, Apotex Inc, Bausch And Lomb, Epic Pharma Llc, Fdc Ltd, Mankind Pharma, Sandoz, Sentiss, Amneal, Caplin, Hikma, Cadila Pharms Ltd, Dr Reddys Labs Ltd, Larken Labs, Ranbaxy Labs Ltd, and Teva. and is included in twenty-five NDAs.
The generic ingredient in OFLOXACIN is ofloxacin. There are seventy-eight drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ofloxacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ofloxacin
A generic version of OFLOXACIN was approved as ofloxacin by LARKEN LABS on September 2nd, 2003.
Summary for OFLOXACIN
Recent Clinical Trials for OFLOXACIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
IVIEW Therapeutics Inc. | Phase 2 |
Centre Hospitalier Universitaire, Amiens | N/A |
University Hospital of Patras | Phase 4 |
Pharmacology for OFLOXACIN
Drug Class | Quinolone Antimicrobial |
Medical Subject Heading (MeSH) Categories for OFLOXACIN
Anatomical Therapeutic Chemical (ATC) Classes for OFLOXACIN
US Patents and Regulatory Information for OFLOXACIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ranbaxy Labs Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 076220-003 | Sep 2, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Larken Labs | OFLOXACIN | ofloxacin | TABLET;ORAL | 076093-002 | Sep 2, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva | OFLOXACIN | ofloxacin | TABLET;ORAL | 076182-001 | Sep 2, 2003 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |